Related Articles
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells
EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway
miRNA-301a induces apoptosis of chronic myelogenous leukemia cells by directly targeting TIMP2/ERK1/2 and AKT pathways
Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition